The Power of Real-World Data
Real-world data (RWD) is transforming how life sciences organizations bring therapies to market and ensure patients get access to the treatments they need. NorstellaLinQ powers MMIT with 74 billion+ data points, turning unstructured and structured information into insights that drive payer strategy, prescriber targeting, and commercial execution. With advanced analytics, natural language processing (NLP), and predictive models, life sciences teams can uncover patient journeys, physician decision-making, and access challenges—fueling smarter, faster commercialization strategies.
Brand teams use predictive analytics to anticipate clinical symptoms triggering earlier diagnosis, drug switches and behavior drivers.
Pharma teams analyze physician notes to uncover decision-making sentiment and connect patient adherence to clinical outcomes — or reimbursement challenges.
Commercial teams hyper-target patients using clinical criteria to reach treating physicians.